Precision BioSciences, Inc. (DTIL) Social Stream



Precision BioSciences, Inc. (DTIL): $4.59

-0.38 (-7.65%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add DTIL to Watchlist
Sign Up

Industry: Biotech


Ranked

of 459

in industry

Precision Biosciences Inc (DTIL) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering DTIL.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
5 $24 $11 $18.25 $6.49 181.2%
5 $26 $13 $20 $6.49 208.17%
5 $24 $13 $19.5 $6.49 200.46%
5 $24 $13 $18.75 $6.49 188.91%

The Trend in the Analyst Price Target


Over the past 34 weeks, DTIL's average price target has gone down $0.38.

Over the past 18 months, DTIL's average upside potential has been 69.9%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-13 5 24 11 18.25 8.23 121.75%
2020-06-09 8 25 7 19.86 NA NA%

DTIL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.4 4 0 1 0 0 5

The Trend in the Broker Recommendations


DTIL's average broker recommendation rating worsened by 0.11 over the prior 16 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, Precision Biosciences Inc's upside potential (average analyst target price relative to current price) is greater than 358.33% of them.
  • Precision Biosciences Inc's variance in analysts' estimates is lower than -221.22% of all US stocks.
  • DTIL has a higher average analyst price target than 93.16% of all US stocks.
  • In the context of stocks in the small market cap category, Precision Biosciences Inc's number of analysts covering the stock is greater than 265.32% of them.

Stocks similar to Precision Biosciences Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ZYNE, ERAS and SRRK.

Is DTIL a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7624 seconds.